Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

330
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
330
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

296
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
296
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

962
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
962
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

552
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
552
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

655
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
655
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.7K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of blood eosinophilia and its impact on lung functions in stable chronic obstructive pulmonary disease patients.

Lung India : official organ of Indian Chest Society·2026
Same author

Clinical Profile and Predictors of Asthma-Chronic Obstructive Pulmonary Disease Overlap in a Tertiary Care Population in North India.

Cureus·2026
Same author

Mitochondrial DNA-mediated cGAS-STING activation and its crosstalk with NLRP3 inflammasome in chronic obstructive pulmonary disease.

Cytokine & growth factor reviews·2026
Same author

Fine needle aspiration cytology in diagnosing tubercular mastitis: A rare entity with differential diagnoses and learning points.

The Indian journal of tuberculosis·2026
Same author

The role of NAT2 genetic variants in anti-tuberculosis drug-induced liver injury (AT-DILI): a meta-analysis.

Pharmacogenomics·2026
Same author

Role of diaphragmatic ultrasound in the assessment of disease severity in stable interstitial lung disease patients.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2026

Related Experiment Video

Updated: Nov 26, 2025

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.9K

Case finding strategies under National Tuberculosis Elimination Programme (NTEP).

Varinder Saini1, Kranti Garg2

  • 1Department of Pulmonary Medicine, Government Medical College and Hospital, Sector 32, Chandigarh, India.

The Indian Journal of Tuberculosis
|December 14, 2020
PubMed
Summary

Finding Tuberculosis (TB) cases remains a global challenge, hindering progress towards the End TB Strategy. This review explores obstacles and strategies for improved TB case finding, emphasizing its critical importance.

Keywords:
Active case findingPassive case findingTuberculosis

More Related Videos

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
12:17

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

Published on: May 8, 2017

12.2K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.4K

Related Experiment Videos

Last Updated: Nov 26, 2025

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.9K
An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
12:17

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

Published on: May 8, 2017

12.2K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.4K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • Tuberculosis (TB) case finding is crucial for achieving global elimination goals but remains a significant challenge.
  • Despite advancements in diagnostics and healthcare access, current strategies fall short of End TB Strategy targets.
  • The National Strategic Plan 2017-2025 highlights the paramount importance of effective TB case finding.

Purpose of the Study:

  • To identify obstacles hindering effective Tuberculosis (TB) case finding.
  • To explore and evaluate various case finding strategies based on diagnostics, feasibility, and resource utilization.
  • To discuss the need for prioritized and participatory approaches to TB case finding.

Main Methods:

  • Literature review and analysis of current case finding strategies for Tuberculosis (TB).
  • Identification of challenges and obstacles in implementing effective TB case finding.
  • Exploration of diagnostic, feasibility, and resource utilization aspects of different strategies.
  • Review of current recommendations and research areas for strengthening TB case finding.

Main Results:

  • Significant obstacles persist in Tuberculosis (TB) case finding, impacting progress towards elimination goals.
  • Various strategies exist, but their effectiveness varies based on diagnostic capabilities, feasibility, and resource allocation.
  • Prioritization, universal participation, and targeted health education are essential for enhancing TB case finding.
  • Resource diversion due to the COVID-19 pandemic further complicates TB case finding efforts.

Conclusions:

  • Heightened efforts and innovative strategies are urgently needed to improve Tuberculosis (TB) case finding.
  • Addressing obstacles and optimizing resource utilization are critical for achieving the End TB Strategy targets.
  • The global health landscape, including the COVID-19 pandemic, necessitates a renewed focus on strengthening TB case finding initiatives.